Fermentation Technology of Ganoderma lucidum and Cordyceps militaris : Advances in Process Optimization, Bioactive Compound Transformation, and Functional Food Development
Clicks: 17
ID: 328082
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
4.8
/100
17 views
16 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #50 of 72 articles by views in letters in applied microbiology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The growing global demand for functional foods has intensified interest in the biotechnological exploitation of medicinal mushrooms. Ganoderma lucidum and Cordyceps militaris are the two most widely recognised medicinal mushrooms in China, each possessing a well-characterised repertoire of bioactive compounds including polysaccharides, triterpenoids, and cordycepin. This review adopts a substrate-process-product framework to systematically evaluate how submerged fermentation, solid-state fermentation, and co-fermentation strategies influence the yield, structural diversity, and bioactivity of these compounds. Key process innovations are critically assessed, including two-stage temperature control, fed-batch operation, exogenous elicitor supplementation, and bidirectional solid-state fermentation on medicinal herb matrices. The translation of fermentation outputs into functional food formats is surveyed, and the persistent gap between in vitro bioactivity data and clinical validation is highlighted. Future progress will require multi-omics-guided strain engineering, artificial-intelligence-driven process control, and rigorous human intervention trials to substantiate functional efficacy claims.
| Reference Key |
openalex_W7212125971
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Junfei Zhu, Yuliang Wang, Hongrui Lv |
| Journal | letters in applied microbiology |
| Year | 2026 |
| DOI |
10.1093/lambio/ovag077
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.